Drug intelligence / Profile preview

carboxyatractyloside

Development stage
Unknown
Modality
Small Molecules
01

Overview

Carboxyatractyloside is a highly toxic diterpene glycoside found in certain plants such as Xanthium species and Atractylis gummifera. It acts as a potent inhibitor of the mitochondrial ADP/ATP translocase (also known as the adenine nucleotide translocator), thereby blocking the exchange of ADP and ATP across the inner mitochondrial membrane. This inhibition disrupts oxidative phosphorylation and cellular energy metabolism. Carboxyatractyloside is about ten times more potent than its analog atractyloside and is not reversible by increasing concentrations of adenine nucleotides. Its toxicity has been implicated in both human and livestock poisonings[4][2][5]. The compound has no approved pharmaceutical use but is used experimentally to study mitochondrial function.

Other names
gummiferincarboxyatractyloside dipotassiumcarboxyatractyloside tripotassium
02

Targets

ANT1/2/3 (Mitochondrial ADP/ATP translocase)

Beyond the preview

Go deeper on carboxyatractyloside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxyatractyloside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call